This story has been updated to include information from a conference call to discuss Quidel's earnings.

NEW YORK (GenomeWeb) – Quidel reported after the close of the market on Wednesday that its second quarter revenues rose 11 percent year over year due primarily to sales of infectious disease and women's health products.

Revenues for the three months ended June 30 increased to $39.1 million from $34.9 million in Q2 2015, above the average analysts' estimate of $38 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.